CXCL8 and non-small cell lung carcinoma: These results together indicate that IL-8 is required for osteolytic bone metastasis of NSCLC cells in nude mice, supporting the therapeutic efficacy of IL-8 neutralizing antibody against osteolytic bone metastasis of lung cancer.